<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2021</study_start_year><data_sharing_plan>IPD Sharing (as of June 2023): No</data_sharing_plan><condition>Inflammatory Bowel Diseases</condition><condition>Intestinal Diseases</condition><condition>Colon Cancer</condition><condition>Colonic Neoplasms</condition><disease>Inflammatory Bowel Diseases</disease><disease>Intestinal Diseases</disease><disease>Colon Cancer</disease><disease>Colonic Neoplasms</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2378287</full_dataset_link><location>France</location><study_start_month>4</study_start_month><keyword>Intestinal Bowel syndrome</keyword><keyword>Data and biological collection</keyword><keyword>Inflammatory Bowel Disease</keyword><keyword>Colon cancer screening</keyword><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Chronic Intestinal Pathologies Analytical Cohort at TouLouse</name><description>In the general population, the percentage of people with at least one digestive disease is 16.7%. Among these digestive diseases, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and patients who should benefit from digestive examinations as part of a screening oriented either by the patient’s family history or following the performance of an immunological screening test ( FIT) in the stool will be studied. The aim of this project is to build a biological collection with associated clinical data for research projects.</description><dates><creation>2021-04-15</creation></dates><accession>2378287</accession><cross_references><ClinicalTrials___gov>NCT04896684</ClinicalTrials___gov></cross_references></HashMap>